Skip to content

AVEO Pharmaceuticals, Inc.: filings

Every AVEO Pharmaceuticals, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 46 filings, each linked to its SEC index.

Filing record ends 2022-11-07

The latest filing in this captured record is a 10-Q filed 2022-11-07. No later filing is in the SEC companyfacts record captured on 2026-09-22. AVEO Pharmaceuticals, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2022-11-07fiscal Q3 2022401140001628280-22-028635
10-Q2022-08-04fiscal Q2 2022401100001628280-22-021160
10-Q2022-05-05fiscal Q1 202240840001628280-22-012410
10-K2022-03-14fiscal FY 2021431900001628280-22-006093
10-Q2021-11-08fiscal Q3 2021421200001628280-21-022223
10-Q2021-08-05fiscal Q2 202136950001564590-21-041703
10-Q2021-05-10fiscal Q1 202136720001564590-21-026089
10-K2021-03-16fiscal FY 2020441730001564590-21-013607
10-Q2020-11-09fiscal Q3 2020431170001564590-20-052556
10-Q2020-08-10fiscal Q2 2020391000001564590-20-038899
10-Q2020-04-30fiscal Q1 202040800001564590-20-019921
10-K2020-03-16fiscal FY 2019391660001564590-20-011145
10-Q2019-11-12fiscal Q3 2019361090001564590-19-042532
10-Q2019-08-08fiscal Q2 2019351030001564590-19-030755
10-Q2019-05-09fiscal Q1 201937760001564590-19-017952
10-K2019-03-14fiscal FY 2018421810001564590-19-007804
10-Q2018-11-09fiscal Q3 201834870001564590-18-028722
10-Q2018-08-07fiscal Q2 2018391050001564590-18-019933
10-Q2018-05-08fiscal Q1 201829590001564590-18-011444
10-K2018-03-13fiscal FY 2017351290001564590-18-005386
10-Q2017-11-07fiscal Q3 201729780001564590-17-021987
10-Q2017-08-09fiscal Q2 201728760001193125-17-252007
10-Q2017-05-04fiscal Q1 201728570001193125-17-157164
10-K2017-03-22fiscal FY 2016321130001564590-17-005015
10-Q2016-11-04fiscal Q3 201635960001564590-16-027498
10-Q2016-08-04fiscal Q2 201630790001564590-16-022491
10-Q2016-05-10fiscal Q1 201632640001564590-16-018921
10-K2016-03-15fiscal FY 2015361230001564590-16-014772
10-Q2015-11-09fiscal Q3 2015371010001564590-15-010037
10-Q2015-08-10fiscal Q2 201531820001564590-15-006740
10-Q2015-05-07fiscal Q1 201532640001193125-15-175776
10-K2015-03-06fiscal FY 2014351250001193125-15-079651
10-Q2014-11-05fiscal Q3 201433870001193125-14-398480
10-Q2014-08-11fiscal Q2 201432860001193125-14-304849
10-Q2014-05-07fiscal Q1 201435700001193125-14-187472
10-K2014-03-13fiscal FY 2013421480001193125-14-097636
10-Q2013-11-07fiscal Q3 201335890001193125-13-431364
10-Q2013-08-08fiscal Q2 201335910001193125-13-325425
10-Q2013-05-10fiscal Q1 201335750001193125-13-214130
10-K2013-03-11fiscal FY 2012411560001193125-13-101343
10-Q2012-11-08fiscal Q3 2012391080001193125-12-460477
10-Q2012-08-07fiscal Q2 2012391080001193125-12-341232
10-Q2012-05-09fiscal Q1 201237760001193125-12-222350
10-K2012-03-30fiscal FY 201138990001193125-12-141748
10-Q2011-11-08fiscal Q3 2011371020001193125-11-302338
10-Q2011-08-09fiscal Q2 2011371020001193125-11-216607

Inspect the source

Entity
AVEO Pharmaceuticals, Inc. / CIK 0001325879
Captured
SEC response SHA-256
21053fe6782ba81440d08f448d6550d472a314e4c7a3593116292fa1b36bb710

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001325879.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))